| 日付 |
時間 |
ソース |
タイトル |
|---|
| 2024/5/02 | 22:00 | BW | Amylyx Pharmaceuticals to Report First Quarter 2024.. |
| 2024/4/10 | 22:00 | BW | Amylyx Pharmaceuticals Announces Interim Data From Ongoing.. |
| 2024/4/09 | 18:45 | PRNUS | The Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc... |
| 2024/4/08 | 22:00 | BW | Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss.. |
| 2024/4/05 | 18:45 | PRNUS | Amylyx Pharmaceuticals, Inc. Sued for Securities Law.. |
| 2024/4/04 | 20:00 | BW | Amylyx Pharmaceuticals Announces Formal Intention to Remove.. |
| 2024/4/02 | 18:45 | PRNUS | The Gross Law Firm Reminds Amylyx Pharmaceuticals, Inc... |
| 2024/3/29 | 18:45 | PRNUS | The Gross Law Firm Announces the Filing of a Securities.. |
| 2024/3/26 | 18:45 | PRNUS | Shareholders of Amylyx Pharmaceuticals, Inc. Should Contact.. |
| 2024/3/25 | 21:00 | PRNUS | INVESTOR ALERT: AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX).. |
| 2024/3/22 | 18:45 | PRNUS | The Gross Law Firm Notifies Shareholders of Amylyx.. |
| 2024/3/19 | 18:45 | PRNUS | Amylyx Pharmaceuticals, Inc. Sued for Securities Law.. |
| 2024/3/14 | 22:00 | BW | Amylyx Pharmaceuticals Appoints Bernhardt Zeiher, MD, FCCP,.. |
| 2024/3/14 | 18:50 | PRNUS | The Gross Law Firm Reminds Shareholders of a Lead Plaintiff.. |
| 2024/3/11 | 21:44 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
| 2024/3/11 | 18:50 | PRNUS | Amylyx Pharmaceuticals, Inc. Class Action: The Gross Law.. |
| 2024/3/08 | 21:10 | EDGAR2 | Form 8-K - Current report |
| 2024/3/08 | 21:00 | BW | Amylyx Pharmaceuticals Announces Topline Results From Global.. |
| 2024/3/08 | 06:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/3/08 | 06:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/3/08 | 06:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/3/07 | 19:45 | PRNUS | Amylyx Pharmaceuticals, Inc. Sued for Securities Law.. |
| 2024/2/29 | 08:22 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/2/29 | 08:20 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/2/29 | 08:13 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/2/28 | 07:59 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/2/26 | 19:45 | PRNUS | AMLX LAWSUIT ALERT: The Gross Law Firm Notifies Amylyx.. |
| 2024/2/24 | 06:05 | BW | Amylyx Pharmaceuticals Announces Inducement Grants Under.. |
| 2024/2/23 | 06:29 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
| 2024/2/22 | 22:22 | EDGAR2 | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 2024/2/22 | 21:08 | EDGAR2 | Form 8-K - Current report |
| 2024/2/22 | 21:00 | BW | Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year.. |
| 2024/2/22 | 19:45 | PRNUS | Amylyx Pharmaceuticals, Inc. Class Action: The Gross Law.. |
| 2024/2/16 | 06:05 | BW | Amylyx Pharmaceuticals to Report Fourth Quarter and Full.. |
| 2024/2/15 | 23:00 | BW | Amylyx Pharmaceuticals to Present Updates on its AMX0114 and.. |
| 2024/2/15 | 19:00 | PRNUS | Lost Money on Amylyx Pharmaceuticals, Inc.(AMLX)? Join Class.. |
| 2024/2/08 | 23:00 | BW | Amylyx Pharmaceuticals Announces Completion of Enrollment in.. |
| 2024/1/12 | 07:11 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/1/12 | 07:10 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/12/30 | 06:07 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/12/22 | 23:00 | BW | Amylyx Pharmaceuticals Announces First Participant Dosed in.. |
| 2023/12/20 | 06:37 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/12/07 | 21:00 | EDGAR2 | Form 8-K - Current report |
| 2023/12/04 | 23:00 | BW | Amylyx Pharmaceuticals Announces Publication of Data Showing.. |
| 2023/11/30 | 07:15 | BW | Amylyx Pharmaceuticals Announces Inducement Grants Under.. |
| 2023/11/28 | 21:00 | BW | Amylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as.. |
| 2023/11/27 | 23:00 | BW | RELYVRIO® and AMX0114 Data to be Presented at 34th.. |
| 2023/11/21 | 23:00 | BW | Amylyx Pharmaceuticals to Participate at the 6th Annual.. |
| 2023/11/21 | 10:20 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/11/09 | 21:07 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
Hot Features
プレミアム
登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
